Diane joined Sarepta as Vice President of Global Health Policy and Government Affairs in 2011. Previously she worked for the federal government, including the Departments of Homeland Security and Defense, overseeing and implementing science and technology and public health activities. Immediately prior to joining Sarepta, Diane served as a Subcommittee Staff Director and Senior Professional Staff Member for the House Committee on Homeland Security.

Alexander J. Varond works on drug development and medical devices, advertising and promotion, and enforcement issues. He counsels clients on drug development matters such as clinical trial design, REMS, orphan drug designation, formal dispute resolution, and patent and exclusivity issues. Mr. Varond also supports ongoing litigation efforts and performs due diligence for corporate transactions.

Pat Furlong is the Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest nonprofit organization in the United States solely focused on Duchenne muscular dystrophy (Duchenne). Their mission is to end Duchenne. They accelerate research, raise their voices in Washington, demand optimal care for all young men, and educate the global community.

Dr. Gerry Cox is Chief Medical Officer at Editas Medicine, a leading genomic medicines company. He was formerly Vice President of Clinical Development for Rare Diseases at Sanofi Genzyme, where for 16 years he oversaw the clinical development programs for several lysosomal storage disorders, including three drug approvals. Dr. Cox is a board-certified clinical geneticist and pediatrician who sees patients part-time at Boston Children’s Hospital, where he was previously on staff and completed his pediatrics and genetics training. He is an instructor in pediatrics at Harvard Medical School. Dr. Cox received a BA in biology from Harvard College in 1980 and an MD, PhD from UCSD in 1989.